Biomarin

Ascendis trial data piles pressure on BioMarin
BioPharma Dive
Wed, 09/18/24 - 01:42 pm
Ascendis Pharma
Biomarin
Voxzogo
achondroplasia
What 3 layoff stories reveal about pharma’s troubles
Pharma Voice
Fri, 09/6/24 - 10:48 am
layoffs
Bayer
Tome Biosciences
Biomarin
BioMarin, having retrenched, outlines plans for growth
BioPharma Dive
Wed, 09/4/24 - 10:54 pm
Biomarin
BioMarin cuts deeper with 225 layoffs under CEO's new corporate strategy
Fierce Pharma
Thu, 08/29/24 - 11:18 am
Biomarin
layoffs
Roche tops pharma rivals for reputation among rare disease patient groups
Medical Marketing and Media
Wed, 08/21/24 - 11:39 am
Roche
reputation
Rare Diseases
Biomarin
Amgen
BioMarin creates new-look R&D and deal teams with Roche’s Sabry, Amgen’s Friberg
Fierce Biotech
Wed, 08/21/24 - 11:31 am
Biomarin
R&D
Roche
Amgen
BioMarin Narrows Roctavian Efforts to U.S., Germany, Italy as Sales Stagnate
BioSpace
Tue, 08/6/24 - 11:23 am
Biomarin
Roctavian
hemophilia A
Germany
Italy
BioMarin sheds 170 jobs in wake of narrowed R&D refocus
Fierce Biotech
Wed, 05/15/24 - 11:37 am
Biomarin
layoffs
restructuring
R&D
BioMarin’s Voxzogo shows promise in hypochondroplasia
Pharmaphorum
Fri, 04/12/24 - 11:02 am
Biomarin
Voxzogo
hypochondroplasia
BioMarin Hit with DOJ Subpoena on Sponsored Testing for Rare Diseases
BioSpace
Tue, 02/27/24 - 11:31 am
Biomarin
SEC
DOJ
Vimizim
Naglazyme
BioMarin preaches patience amid slow sales for hemophilia gene therapy
BioPharma Dive
Fri, 02/23/24 - 10:26 am
Biomarin
Roctavian
earnings
gene therapy
hemophilia
Top 5 Life Science Companies Hiring Remote
BioSpace
Thu, 01/18/24 - 11:12 am
remote work
hirings
Takeda
AbbVie
Moderna Therapeutics
Biomarin
CSL Behring
BioMarin settles with Elliott, adds 3 independent directors
Reuters
Thu, 12/21/23 - 09:47 am
Biomarin
Elliott Management
BioMarin secures hemophilia gene therapy coverage in Germany
BioPharma Dive
Wed, 11/29/23 - 11:35 pm
Biomarin
Roctavian
gene therapy
Germany
hemophilia
Activist investor Elliott targets drugmaker BioMarin -sources
Reuters
Tue, 11/7/23 - 11:03 pm
Biomarin
Elliott Management
BioMarin’s longtime CEO Jean-Jacques Bienaimé hands the reins to Genentech’s Alexander Hardy
Fierce Pharma
Wed, 11/1/23 - 10:20 pm
Biomarin
Pharma CEOs
Jean-Jacques Bienaimé
Alexander Hardy
Genentech
BioMarin's share prices fluctuate following Phase 3 clinical trial results
Yahoo/Investing.com
Mon, 09/18/23 - 07:54 pm
Biomarin
Roctavian
clinical trials
With Roctavian as a launching pad, BioMarin looks to up pace of new drug filings
Fierce Biotech
Tue, 09/12/23 - 07:17 pm
Biomarin
Roctavian
hemophilia A
Voxzogo
achrondoplasia
drug development
gene therapy
Voxzogo saves the day for Biomarin
EP Vantage
Tue, 08/1/23 - 10:05 am
Biomarin
hemophilia A
gene therapy
Roctavian
Voxzogo
5 Highly Anticipated FDA Decisions for Rare Diseases Coming This Year
BioSpace
Fri, 07/28/23 - 11:46 am
Ipsen
palovarotene
fibrodysplasia ossificans progressiva
Regeneron
CHAPLE disease
pozelimab
Biomarin
Voxzogo
achondroplasia
Santhera Pharmaceuticals
vamorolone
DMD
Springworks
nirogacestat
desmoid tumors

Pages